These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
394 related items for PubMed ID: 8643525
1. Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Bao J, Sharp AH, Wagster MV, Becher M, Schilling G, Ross CA, Dawson VL, Dawson TM. Proc Natl Acad Sci U S A; 1996 May 14; 93(10):5037-42. PubMed ID: 8643525 [Abstract] [Full Text] [Related]
4. Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Li SH, Li XJ. Trends Genet; 2004 Mar 01; 20(3):146-54. PubMed ID: 15036808 [Abstract] [Full Text] [Related]
5. DMSO and glycerol reduce bacterial death induced by expression of truncated N-terminal huntingtin with expanded polyglutamine tracts. Nagao Y, Ishiguro H, Nukina N. Biochim Biophys Acta; 2000 Oct 18; 1502(2):247-56. PubMed ID: 11040449 [Abstract] [Full Text] [Related]
6. Calmodulin regulates transglutaminase 2 cross-linking of huntingtin. Zainelli GM, Ross CA, Troncoso JC, Fitzgerald JK, Muma NA. J Neurosci; 2004 Feb 25; 24(8):1954-61. PubMed ID: 14985437 [Abstract] [Full Text] [Related]
8. Neuroprotective effects of calmodulin peptide 76-121aa: disruption of calmodulin binding to mutant huntingtin. Dudek NL, Dai Y, Muma NA. Brain Pathol; 2010 Jan 25; 20(1):176-89. PubMed ID: 19338577 [Abstract] [Full Text] [Related]
9. Expression of the Huntington's disease (IT15) protein product in HD patients. Schilling G, Sharp AH, Loev SJ, Wagster MV, Li SH, Stine OC, Ross CA. Hum Mol Genet; 1995 Aug 25; 4(8):1365-71. PubMed ID: 7581375 [Abstract] [Full Text] [Related]
10. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Jana NR, Zemskov EA, Wang Gh, Nukina N. Hum Mol Genet; 2001 May 01; 10(10):1049-59. PubMed ID: 11331615 [Abstract] [Full Text] [Related]
12. Huntington's disease gene product, huntingtin, associates with microtubules in vitro. Tukamoto T, Nukina N, Ide K, Kanazawa I. Brain Res Mol Brain Res; 1997 Nov 01; 51(1-2):8-14. PubMed ID: 9427501 [Abstract] [Full Text] [Related]
13. Effects of overexpression of huntingtin proteins on mitochondrial integrity. Wang H, Lim PJ, Karbowski M, Monteiro MJ. Hum Mol Genet; 2009 Feb 15; 18(4):737-52. PubMed ID: 19039036 [Abstract] [Full Text] [Related]
14. In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease. Hackam AS, Singaraja R, Zhang T, Gan L, Hayden MR. Hum Mol Genet; 1999 Jan 15; 8(1):25-33. PubMed ID: 9887328 [Abstract] [Full Text] [Related]
17. Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats. Li SH, Li XJ. Hum Mol Genet; 1998 May 15; 7(5):777-82. PubMed ID: 9536080 [Abstract] [Full Text] [Related]
19. PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains. Modregger J, DiProspero NA, Charles V, Tagle DA, Plomann M. Hum Mol Genet; 2002 Oct 01; 11(21):2547-58. PubMed ID: 12354780 [Abstract] [Full Text] [Related]